Picture of Dicot Pharma AB logo

DICOT Dicot Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Dicot AB Will Move On To Toxicological Studies That Are Expected To Be Completed In Autumn Of 2021

Jan 29 (Reuters) - Dicot AB  DICOT.TE :
    * DICOT INITIATES TOXICOLOGY STUDIES BEFORE APPLYING FOR CLINICAL TRIALS
    * DICOT AB - PROGRAM RUNS UNTIL AUTUMN AND WILL FORM BASIS FOR AN APPLICATION FOR CLINICAL
TRIALS
ON HUMANS
    * DICOT AB - IN ACCORDANCE WITH DICOT'S DEVELOPMENT PLAN, COMPANY WILL MOVE ON TO
TOXICOLOGICAL
STUDIES THAT ARE EXPECTED TO BE COMPLETED IN AUTUMN OF 2021

Source text for Eikon:  ID: 
Further company coverage:  DICOT.TE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Dicot Pharma AB

See all news